81
TITLE: Nephropathy in Fabry disease: Baseline characteristics of 1262 patients in the Fabry Registry  Full Text
AUTHORS: Christine Eng; Alberto Ortiz; Oliveira, JP ; Steven Waldek; David Warnock; Bruno Cianciaruso; Christoph Wanner;
PUBLISHED: 2008, SOURCE: 4th Annual World Symposium of the Lysosomal-Disease-Network in MOLECULAR GENETICS AND METABOLISM, VOLUME: 93, ISSUE: 2
82
TITLE: Nephropathy in Fabry disease: Baseline characteristics of a cohort of 1262 female and male patients in the Fabry registry
AUTHORS: Ortiz, A; Oliveira, JP ; Waldek, S; Warnock, DG; Cianciaruso, B; Wanner, C;
PUBLISHED: 2008, SOURCE: 8th Annual European Round Table on Fabry Disease in CLINICAL THERAPEUTICS, VOLUME: 30
INDEXED IN: WOS
83
TITLE: Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy
AUTHORS: Alberto Ortiz; Oliveira, JP ; Steven Waldek; David G Warnock; Bruno Cianciaruso; Christoph Wanner;
PUBLISHED: 2008, SOURCE: NEPHROLOGY DIALYSIS TRANSPLANTATION, VOLUME: 23, ISSUE: 5
INDEXED IN: Scopus WOS CrossRef: 161
84
TITLE: PORTYSTROKE: SCREENING GENETIC CONDITIONS IN PORTUGUESE YOUNG STROKE PATIENTS
AUTHORS: Viana Baptista, M; Ferreira, S; Melo, TP; Carvalho, M; Cruz, VT ; Carmona, C; Tuna, A; Rodrigues, M; Ferreira, C; Pinto, AN; Silva, FA; Leitao, A; Gabriel, JP; Calado, S; Oliveira, JP ; Ferro, JM;
PUBLISHED: 2008, SOURCE: 5th Symposium on Lysosomal Storage Disorders in CLINICAL THERAPEUTICS, VOLUME: 30
INDEXED IN: WOS
85
TITLE: Recommendations and guidelines for the diagnosis and treatment of Fabry nephropathy in adults
AUTHORS: Alberto Ortiz; Oliveira, JP ; Christoph Wanner; Barry M Brenner; Stephen Waldek; David G Warnock;
PUBLISHED: 2008, SOURCE: NATURE CLINICAL PRACTICE NEPHROLOGY, VOLUME: 4, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef: 64
86
TITLE: Significant proteinuria reduction in Fabry disease after a short period of combined enzyme replacement therapy and angiotensin-converting enzyme inhibitor
AUTHORS: Soares, C; Faria, B; Sousa, T; Garrido, J; Lemos, S; Oliveira, JP ;
PUBLISHED: 2008, SOURCE: 8th Annual European Round Table on Fabry Disease in CLINICAL THERAPEUTICS, VOLUME: 30
INDEXED IN: WOS
87
TITLE: Splenomegaly, hypersplenism and peripheral blood cytopaenias in patients with classical Anderson-Fabry disease  Full Text
AUTHORS: Oliveira, JP ; Carmen Valbuena ; Antonio Baldaia Moreira; Elsa Fonseca ; Carlos Soares; Elisa Leao Teles; Stephen Waldek;
PUBLISHED: 2008, SOURCE: VIRCHOWS ARCHIV, VOLUME: 453, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef: 8
89
TITLE: Evidence for selective low leukocyte enzyme activity levels associated with the G1170C > T 5 ' untranslated polymorphism of the alpha-galactosidase A gene  Full Text
AUTHORS: Ferreira, S; Barcelo, J; Carvalho, F ; Mansson, JE; Oliveira, JP ;
PUBLISHED: 2007, SOURCE: 7th Annual European Round Table on Fabry Disease in CLINICAL THERAPEUTICS, VOLUME: 29
INDEXED IN: WOS CrossRef
90
TITLE: Fabry disease: Worsening of hearing loss with enzyme replacement therapy  Full Text
AUTHORS: Moura, C; Soares, C; Seixas, D; Ayres Bastos, M; Pais Clemente, M; Oliveira, JP ;
PUBLISHED: 2007, SOURCE: 7th Annual European Round Table on Fabry Disease in CLINICAL THERAPEUTICS, VOLUME: 29
Page 9 of 11. Total results: 109.